K

IRYAT SHMONA, Israel — As you drive toward the industrial park in this border town, you pass a disquieting sight: the abandoned skeleton of a thread factory that shuttered 18 years ago. Broken glass litters the concrete floor, and behind a door condemned with “NO PASSAGE” in red spray paint, huge canisters lean against one another like dead bodies.

It’s a foreboding omen of what could happen if the world’s largest generic drug manufacturer, Teva Pharmaceutical Industries, were to pull out of this northern Israeli city.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.